Science Friday

This week, an FDA advisory committee met to pore over data and debate the role of COVID vaccine boosters. And on Thursday, they voted to recommend Moderna boosters for older Americans, as well as people in certain at-risk groups. This recommendation came just a few weeks after the FDA authorized a Pfizer booster for similar individuals.

The recommendations of the panel regarding boosters for Moderna and Johnson & Johnson vaccines, as well as the idea of mixing and matching different vaccine and booster types, will now go to FDA officials. The CDC will also weigh in.

Amy Nordrum, commissioning editor at MIT Technology Review, joins Ira to talk about the vaccine meeting and other topics from the week in science—including the FDA authorization of an e-cigarette, efforts to map the brain, mysterious radio signals from space, and a mission to explore asteroids near Jupiter.

Monday was Indigenous Peoples’ Day here in the United States: a holiday to honor Native Americans and their resilience over many centuries of colonialism. Due to a long history of discrimination, Native Americans face stark health disparities, compared to other American populations. Illnesses like chronic liver disease, diabetes, and respiratory diseases are much more common in Native communities.

This is where the Native BioData Consortium (NBDC) comes in. It’s a biobank, a large collection of biological samples for research purposes. What sets this facility apart from others is its purpose—the biological samples are from indigenous people, and the research is led by indigenous scientists.

This is important, say the founders, because for too long, biological samples from Native people have been used for purposes that don’t benefit them.

Joining Ira to talk about the importance of having a biobank run by indigenous scientists are three foundational members of the project: Krystal Tsosie, co-founder and ethics and policy director of the NBDC and PhD candidate in genetics at Vanderbilt University, Joseph Yracheta, executive director and laboratory manager of the NCDC, and Matt Anderson, assistant professor of microbiology at Ohio State University and NCDC board member.

This summer, Science Friday and other media outlets covered the protests against an oil pipeline project in northern Minnesota, where Canadian company Enbridge Energy was replacing and expanding their existing Line 3 infrastructure. Native American tribes in Minnesota—whose lands the pipeline would pass through and alongside—organized protests, direct action, and other resistance against the project. The pipeline was completed, and began moving tar sands oil at the beginning of October.

But the protests and their non-Native allies drew arrests, news coverage, and social media attention to the debate over continued drilling of fossil fuels.

Before Line 3, there were protests at the Dakota Access Pipeline, which was completed against the wishes of the nearby Standing Rock Sioux Tribe, and the Keystone XL pipeline, which President Biden ultimately cancelled after objections and lawsuits from two Native American communities in Montana and South Dakota. So far, the Arctic National Wildlife Refuge has remained un-drilled, despite multiple attempts, with help from vocal opposition by Alaska’s Gwich’in people.

A new report from two advocacy groups does the math on how much carbon dioxide or other greenhouse gas emissions these cancelled or delayed projects would have emitted in the last 10 years. According to their calculations, Indigenous resistance to pipelines and other fossil fuel projects has saved the U.S. and Canada 12% of their annual emissions, or 0.8 billion tons of CO2 per year.

Ira talks to the co-authors, Dallas Goldtooth of the Indigenous Environmental Network, and Kyle Gracey from Oil Change International, about the value of tallying these emissions in the fight to prevent future oil projects. Plus, why Native American protesters and their allies deserve credit for keeping fossil fuels in the ground—and the bigger environmental justice issue of pipeline projects alongside Native land.

The Hot And Cold Past Of The Air Conditioner

In the Northeast, the leaves have started changing colors, heralding the season of pumpkins, sweaters, and the smell of woodsmoke. But in some parts of the country, the heat hasn’t let up. In cities like Dallas, Phoenix, and Miami, temperatures were up in the high 80s and low 90s this week—and with climate change, the U.S. is only getting hotter. 

But humans have come up with an ingenious way to keep the heat at bay: air conditioning. Widely considered one of the greatest engineering achievements of the 20th century, the technology has transformed how and where people live—and it’s prevented countless deaths. But it comes at a cost, and if we’re going to keep up with a warming climate, we’re going to need some other tricks to stay cool. 

Like what you hear? Dive deeper with some of the sources we turned to while reporting.

What happens when you see a familiar face? Light reflected from the face enters your eye, is focused onto the retina, and a signal travels up your optic nerve. But what exactly goes on in your brain after that is still somewhat mysterious.  

Recently, researchers reported in the journal Science that they had identified a group of brain cells that seem tuned to respond only to familiar faces. The theory is that the specificity of those neurons helps to speed up processing of potentially important visual information. The work was done in monkeys, but the researchers are currently trying to identify similar brain structures in people.  

Sofia Landi and Winrich Freiwald, two of the authors of the report, join Ira to talk about the research, and what it may tell us about how the brain and memory are organized. 

Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In the Northeast, the leaves have started changing colors, heralding the season of pumpkins, sweaters, and the smell of woodsmoke. But in some parts of the country, the heat hasn’t let up. In cities like Dallas, Phoenix, and Miami, temperatures were up in the high 80s and low 90s this week—and with climate change, the U.S. is only getting hotter. 

But humans have come up with an ingenious way to keep the heat at bay: air conditioning. Widely considered one of the greatest engineering achievements of the 20th century, the technology has transformed how and where people live—and it’s prevented countless deaths. But it comes at a cost, and if we’re going to keep up with a warming climate, we’re going to need some other tricks to stay cool. 

Like what you hear? Dive deeper with some of the sources we turned to while reporting.

What happens when you see a familiar face? Light reflected from the face enters your eye, is focused onto the retina, and a signal travels up your optic nerve. But what exactly goes on in your brain after that is still somewhat mysterious.  

Recently, researchers reported in the journal Science that they had identified a group of brain cells that seem tuned to respond only to familiar faces. The theory is that the specificity of those neurons helps to speed up processing of potentially important visual information. The work was done in monkeys, but the researchers are currently trying to identify similar brain structures in people.  

Sofia Landi and Winrich Freiwald, two of the authors of the report, join Ira to talk about the research, and what it may tell us about how the brain and memory are organized. 

First Malaria Vaccine Is Approved by WHO

The malaria parasite is one of the world’s deadliest infectious diseases, killing on average about 500,000 people per year—half of them children under the age of 5, nearly all of them in sub-Saharan Africa.

Now, the World Health Organization has finally approved RTS,S or Mosquirix, the first vaccine against Plasmodium falciparum, which is the most deadly strain of the parasite. The vaccine has already been administered via a pilot program to 800,000 children in Kenya, Ghana, and Malawi, and in clinical trials showed an efficacy rate of about 50% against severe disease.

WNYC’s Nsikan Akpan explains this and other stories, including a climate change-linked Nobel Prize in physics, controversy over the naming of the James Webb Space Telescope, and a new surveillance method that uses only the shadows you cast on a blank wall.

Late last week, the pharmaceutical company Merck released data on a new antiviral medication called molnupiravir—a drug taken as a course of pills over five days that the company said was dramatically effective at keeping people with COVID-19 out of the hospital. In a press release, the company said that trial participants on the medication had a 50% lower risk of hospitalization or death compared to people getting the placebo. And while eight people in the placebo group died during the trial, none of the people getting the new drug did.

However, the full data from the trial has yet to be released—and the medication must still go through the FDA approval process before it can be used. Matthew Herper, senior writer at STAT covering medicine, joins Ira to talk about the drug and what questions remain.

Then, infectious disease specialist and epidemiologist Céline Gounder discusses other recent coronavirus news—from a government plan to spend a billion dollars on at-home testing to recent data on the Delta variant, including projections of what might happen next.

The United States has a long history of public health crises. For many, our first pandemic has been COVID-19. But long before the SARS-CoV-2 virus arrived, HIV, measles, and the flu all left a lasting impact. As a wealthy country, you may think the United States would be prepared to deal with public health crises, since they happen here with a degree of regularity. However, that’s not the case.

The longstanding issues that left the country vulnerable to COVID-19 are explored in a recent article from The Atlantic, called “We’re Already Barreling Toward the Next Pandemic.” The piece was written by science writer Ed Yong, who won a Pulitzer Prize last year for his coverage of COVID-19.

Ira speaks to Ed and Gregg Gonsalves, global health activist and epidemiologist at Yale, about the country’s history of public health unpreparedness, and what needs to happen to be ready for the next pandemic.

Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The malaria parasite is one of the world’s deadliest infectious diseases, killing on average about 500,000 people per year—half of them children under the age of 5, nearly all of them in sub-Saharan Africa.

Now, the World Health Organization has finally approved RTS,S or Mosquirix, the first vaccine against Plasmodium falciparum, which is the most deadly strain of the parasite. The vaccine has already been administered via a pilot program to 800,000 children in Kenya, Ghana, and Malawi, and in clinical trials showed an efficacy rate of about 50% against severe disease.

WNYC’s Nsikan Akpan explains this and other stories, including a climate change-linked Nobel Prize in physics, controversy over the naming of the James Webb Space Telescope, and a new surveillance method that uses only the shadows you cast on a blank wall.

Late last week, the pharmaceutical company Merck released data on a new antiviral medication called molnupiravir—a drug taken as a course of pills over five days that the company said was dramatically effective at keeping people with COVID-19 out of the hospital. In a press release, the company said that trial participants on the medication had a 50% lower risk of hospitalization or death compared to people getting the placebo. And while eight people in the placebo group died during the trial, none of the people getting the new drug did.

However, the full data from the trial has yet to be released—and the medication must still go through the FDA approval process before it can be used. Matthew Herper, senior writer at STAT covering medicine, joins Ira to talk about the drug and what questions remain.

Then, infectious disease specialist and epidemiologist Céline Gounder discusses other recent coronavirus news—from a government plan to spend a billion dollars on at-home testing to recent data on the Delta variant, including projections of what might happen next.

The United States has a long history of public health crises. For many, our first pandemic has been COVID-19. But long before the SARS-CoV-2 virus arrived, HIV, measles, and the flu all left a lasting impact. As a wealthy country, you may think the United States would be prepared to deal with public health crises, since they happen here with a degree of regularity. However, that’s not the case.

The longstanding issues that left the country vulnerable to COVID-19 are explored in a recent article from The Atlantic, called “We’re Already Barreling Toward the Next Pandemic.” The piece was written by science writer Ed Yong, who won a Pulitzer Prize last year for his coverage of COVID-19.

Ira speaks to Ed and Gregg Gonsalves, global health activist and epidemiologist at Yale, about the country’s history of public health unpreparedness, and what needs to happen to be ready for the next pandemic.

Looking Back On A Century of Science

In 1921, the discovery of radium was just over 20 years in the past. And the double helix of DNA was still over thirty years in the future. That year, a publication that came to be the magazine Science News started publication, and is still in operation today.

Editors Nancy Shute and Elizabeth Quill join Ira to page through the magazine’s archives, with over 80,000 articles covering a century of science—from the possibilities of atomic energy to discussions of black holes, to projections of the rise of the avocado as a popular fruit. There are mysteries—are spiral nebulae other universes? And there are missteps, like the suggestion that the insecticide DDT should be incorporated into wall paint.

The Science Friday Book Club is kicking off for fall. Producer Christie Taylor joins in a conversation with Elizabeth Rush, author of Rising: Dispatches from the New American Shore. They talk about the surprisingly fascinating science of coastal wetlands, and their role in protecting communities from sea level rise—plus how communities themselves, from Staten Island to southern Louisiana, are responding to rising seas and flooding.

For the full rundown, excerpts, and more, check out our main Book Club page.

Our Charismatic Creature Carnival is coming to a close. Over the last month, SciFri has celebrated six overlooked or unfairly maligned species that deserve a chance under the spotlight. And now, out of our three semifinalist creature candidates, there can only be one winner. Will it be the colorful, tiny, but mighty mantis shrimp? Or perhaps the adaptable, dramatic opossum? Or will the endangered shoebill stork, with its prehistoric look, come out on top? The choice is up to our listeners: vote here.

Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In 1921, the discovery of radium was just over 20 years in the past. And the double helix of DNA was still over thirty years in the future. That year, a publication that came to be the magazine Science News started publication, and is still in operation today.

Editors Nancy Shute and Elizabeth Quill join Ira to page through the magazine’s archives, with over 80,000 articles covering a century of science—from the possibilities of atomic energy to discussions of black holes, to projections of the rise of the avocado as a popular fruit. There are mysteries—are spiral nebulae other universes? And there are missteps, like the suggestion that the insecticide DDT should be incorporated into wall paint.

The Science Friday Book Club is kicking off for fall. Producer Christie Taylor joins in a conversation with Elizabeth Rush, author of Rising: Dispatches from the New American Shore. They talk about the surprisingly fascinating science of coastal wetlands, and their role in protecting communities from sea level rise—plus how communities themselves, from Staten Island to southern Louisiana, are responding to rising seas and flooding.

For the full rundown, excerpts, and more, check out our main Book Club page.

Our Charismatic Creature Carnival is coming to a close. Over the last month, SciFri has celebrated six overlooked or unfairly maligned species that deserve a chance under the spotlight. And now, out of our three semifinalist creature candidates, there can only be one winner. Will it be the colorful, tiny, but mighty mantis shrimp? Or perhaps the adaptable, dramatic opossum? Or will the endangered shoebill stork, with its prehistoric look, come out on top? The choice is up to our listeners: vote here.

Healthcare Is Hard Enough to Get. If You’re A Trans Youth, It’s Even Harder

Healthcare can be difficult to access for anyone—that’s been made clear during the COVID-19 pandemic. But for transgender youth, the barriers are exponentially higher. A new study from the journal JAMA Pediatrics shows that trans youth don’t get the care they need because of a variety of obstacles. Those range from laws that prevent them from advocating for themselves, to stigma from doctors.

Joining Ira to talk about this story and other big science news of the week is Sabrina Imbler, science reporting fellow for the New York Times based in New York City. Ira and Sabrina also discuss the massive undertaking of COVID-19 testing in school districts, and the impacts ivermectin misinformation is having on the livestock and veterinary industries.

If you live in Pennsylvania or any of its surrounding environs, you’ve probably seen a really interesting looking bug in the past few years: the spotted lanternfly. Around this time of year, it’s in its nymph stage. But when fully grown, these lanternflies sound a little like the joke—they’re black and white and red all over. They’ve also got spots, as their name suggests.

The charming news about how interesting they look is offset by the bad news: They are an invasive species. And they frighten crop farmers because they have a taste for just about anything, and a fondness for grapes, which could have dramatic economic consequences.

Many states have a unified stance on what to do if you spy a spotted lanternfly—stomp them out. But is that an effective way to stop their spread? Joining Ira to chat about stomping techniques and lanternfly biology is Julie Urban, associate research professor in entomology at Penn State University, in State College, Pennsylvania.

As of 2017, more than half of primate species—that’s apes, monkeys, lemurs, and our other relatives—were considered at risk of extinction. While the loss of these animals would be its own ecological crisis, this is causing another wave of die offs: the parasites that live on those primates, many of whom are specially adapted to live on just one species for their entire lives. That includes fungi and viruses, as well as the more grimace-inducing parasites like lice and intestinal worms.

Producer Christie Taylor talks to Duke Lemur Center researcher James Herrera, the first author on new research that found if endangered primates do disappear, nearly 200 species of primate parasites might also. They talk about why that loss could have consequences—not just for dwindling primates, but also for us.

Amorous arachnids sing to their lovers without making a sound. Instead, they like to shake things up.

Spiders aren’t powerful enough to vibrate the air, the way actual singing does. Instead, they use the ground. Male spiders send vibrations down their legs, and into whatever they’re standing on. Nearby females “hear” the song vibrating up their legs.

Humans can’t hear these spider songs with our ears, but we can listen to them with the help of a laser doppler vibrometer. This instrument can make non-contact vibration measurements of a surface. It shoots a laser beam at a particular surface, and depending on how much that surface moves, it can then measure the frequency and amplitude of the vibration, based on the Doppler shift of the reflected laser beam.

Hear an example of these lovelorn spiders on The World According to Sound, a live audio show, online listening series, and miniature podcast that focuses on sound, not story. Producers Chris Hoff and Sam Harnett create intentional, communal listening experiences as a way to “reclaim autonomy in a visually dominated world that is increasingly fracturing our attention.” The spiders in this piece were recorded by researchers in Damian Elias’s lab at UC Berkeley.

This recording is part of their next listening series, an immersive listening party where audiences from all over the globe will be invited to experience a world of sound together, beginning in January 2022. You can get a ticket to the series here.

Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Healthcare can be difficult to access for anyone—that’s been made clear during the COVID-19 pandemic. But for transgender youth, the barriers are exponentially higher. A new study from the journal JAMA Pediatrics shows that trans youth don’t get the care they need because of a variety of obstacles. Those range from laws that prevent them from advocating for themselves, to stigma from doctors.

Joining Ira to talk about this story and other big science news of the week is Sabrina Imbler, science reporting fellow for the New York Times based in New York City. Ira and Sabrina also discuss the massive undertaking of COVID-19 testing in school districts, and the impacts ivermectin misinformation is having on the livestock and veterinary industries.

If you live in Pennsylvania or any of its surrounding environs, you’ve probably seen a really interesting looking bug in the past few years: the spotted lanternfly. Around this time of year, it’s in its nymph stage. But when fully grown, these lanternflies sound a little like the joke—they’re black and white and red all over. They’ve also got spots, as their name suggests.

The charming news about how interesting they look is offset by the bad news: They are an invasive species. And they frighten crop farmers because they have a taste for just about anything, and a fondness for grapes, which could have dramatic economic consequences.

Many states have a unified stance on what to do if you spy a spotted lanternfly—stomp them out. But is that an effective way to stop their spread? Joining Ira to chat about stomping techniques and lanternfly biology is Julie Urban, associate research professor in entomology at Penn State University, in State College, Pennsylvania.

As of 2017, more than half of primate species—that’s apes, monkeys, lemurs, and our other relatives—were considered at risk of extinction. While the loss of these animals would be its own ecological crisis, this is causing another wave of die offs: the parasites that live on those primates, many of whom are specially adapted to live on just one species for their entire lives. That includes fungi and viruses, as well as the more grimace-inducing parasites like lice and intestinal worms.

Producer Christie Taylor talks to Duke Lemur Center researcher James Herrera, the first author on new research that found if endangered primates do disappear, nearly 200 species of primate parasites might also. They talk about why that loss could have consequences—not just for dwindling primates, but also for us.

Amorous arachnids sing to their lovers without making a sound. Instead, they like to shake things up.

Spiders aren’t powerful enough to vibrate the air, the way actual singing does. Instead, they use the ground. Male spiders send vibrations down their legs, and into whatever they’re standing on. Nearby females “hear” the song vibrating up their legs.

Humans can’t hear these spider songs with our ears, but we can listen to them with the help of a laser doppler vibrometer. This instrument can make non-contact vibration measurements of a surface. It shoots a laser beam at a particular surface, and depending on how much that surface moves, it can then measure the frequency and amplitude of the vibration, based on the Doppler shift of the reflected laser beam.

Hear an example of these lovelorn spiders on The World According to Sound, a live audio show, online listening series, and miniature podcast that focuses on sound, not story. Producers Chris Hoff and Sam Harnett create intentional, communal listening experiences as a way to “reclaim autonomy in a visually dominated world that is increasingly fracturing our attention.” The spiders in this piece were recorded by researchers in Damian Elias’s lab at UC Berkeley.

This recording is part of their next listening series, an immersive listening party where audiences from all over the globe will be invited to experience a world of sound together, beginning in January 2022. You can get a ticket to the series here.

Pilgrim Nuclear Power Plant To Say Goodbye To Its Radioactive Waste

Just before Thanksgiving, the Pilgrim Nuclear Power Plant in Plymouth is expected to reach a historic milestone. All the radioactive fuel that generated electricity—and controversy—for nearly half a century will finally be removed from the reactor building. It will be stored outside in special steel and cement casks.

The rare occasion will be celebrated by both supporters and opponents of the plant. But as the decommissioning of Pilgrim proceeds, concern over the long-term safety of the highly radioactive waste continues.

Even though Pilgrim Nuclear Power Plant stopped producing electricity two years ago, there are still armed guards in watchtowers, surveillance cameras spread over the site, mazes of barbed wire fences and concrete vehicle barriers. 

Bruce Gellerman, a senior reporter at WBUR in Boston, Massachusetts, explains what the decommissioning process has been like and the future of nuclear power in the Northeast.

Dr. Anthony Fauci became a household name at the beginning of the COVID-19 pandemic. Now, he’s the subject of a children’s book too: Dr: Fauci: How a Boy From Brooklyn Became America’s Doctor. The book takes us back to Fauci’s childhood filled with games of baseball in the streets of Brooklyn, bike rides to deliver medications for his family’s pharmacy, and his long history of asking questions about how the world works.

Author Kate Messner talks to Ira about the surprises she found in Fauci’s life story, the value of showing kids that scientists were once children too, and why curiosity is such an important value to teach children.

It’s the third and final matchup of this fall’s Charismatic Creature Carnival, our celebration of six overlooked, and often unfairly maligned, species that deserve a chance under the spotlight. Our audience submitted the carnival candidates, but only one will be crowned the very first inductee into the Charismatic Creature Corner Hall of Fame.

This week, our match-up is between two fabulous, feathered creatures: the pigeon and the shoebill stork. Defending the pigeon is Elizabeth Carlen, postdoctoral research fellow at Washington University in St. Louis. Representing the shoebill stork is Judith Mirembe, shoebill researcher and chair of Uganda Women Birders based in Kampala, Uganda. 

Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.